Aidigong Maternal & Child Health Limited is an investment holding company primarily engaged in the provision of postpartum care and maternal and child healthcare services in the People's Republic of China. The company operates through three main segments: Postpartum Care Services, Health Industry, and Other segments. Its core products and services include professional postpartum care centers offering 24-hour maternal and infant nursing, personalized nutrition plans, rehabilitation care, yoga shaping, breast management, early education for newborns, and baby photography. In the health industry segment, Aidigong provides medical anti-aging services, natural health food products, healthcare industry investments, and healthcare property development. Founded in 2007 and headquartered in Hong Kong, Aidigong has developed a recognized brand with a proprietary "Nine Professional Care Standard Systems" implemented in its digital management system to ensure consistent high-quality services.
In the past 1-2 years, the company has pursued a strategic expansion under its five-year plan targeting 50 cities across China, rapidly increasing its market presence. Notably, it has launched the "Yuegege" brand postpartum care centers, opening multiple new centers including the third center in Zhuhai in 2023, expanding into Eastern China markets such as Wuxi, and establishing stores in Xiamen, Dongguan, Guangzhou, Quanzhou, and Fuzhou. It has also initiated a new non-residential postpartum care service business under the combined Aidigong brand. As of late 2025, the company operates 19 postpartum care centers across 10 Chinese cities, strengthening its footprint and market share. Aidigong continues to focus on operational efficiency through an ultra-light asset model and enhancement of service quality to drive growth and customer demand. The company’s shares have experienced trading suspension since early 2025, with ongoing corporate governance activities including scheduled special general meetings.
Aidigong’s business serves mainly postpartum mothers and newborns, targeting middle-to-high income segments looking for professional, integrated postpartum and health management solutions. Its operations are concentrated in major urban centers across China, combining healthcare services with investment in healthcare industry development. The company’s strategic efforts in brand development, service systematization, and geographical expansion reflect a robust growth trajectory within the maternal and child healthcare industry in China.